checkAd
    Startseite > Aktien > IGM Biosciences > Nachrichten
    IGM Biosciences Aktie
    8,4100
     
    USD
    +0,48 %
    +0,0400 USD
    Letzter Kurs 02:00:00 Nasdaq
    8,4100
     
    USD
    300 STK
    Geldkurs 21.05.24
    8,4700
     
    USD
    100 STK
    Briefkurs 21.05.24
    ISIN: US4495851085 · WKN: A2PPQK · SYM: IGMS · USA

    Neueste Nachrichten

    IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
    08.05.24 · globenewswire · IGM Biosciences
    IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
    07.05.24 · globenewswire · IGM Biosciences
    IGM Biosciences Announces Refocusing of Sanofi Collaboration
    17.04.24 · globenewswire · IGM Biosciences
    IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
    10.04.24 · globenewswire · IGM Biosciences
    IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    07.03.24 · globenewswire · IGM Biosciences
    IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    01.02.24 · globenewswire · IGM Biosciences
    IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
    03.01.24 · globenewswire · IGM Biosciences
    IGM Biosciences Announces Third Quarter 2023 Financial Results
    13.11.23 · globenewswire · IGM Biosciences
    IGM Biosciences to Present at Two Upcoming Investor Conferences
    07.11.23 · globenewswire · IGM Biosciences
    IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors
    03.10.23 · globenewswire · IGM Biosciences
    IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
    06.09.23 · globenewswire · IGM Biosciences
    E-Autos im Abseits: Bei diesen Aktien rechnen Investoren mit den größten Kursverlusten
    30.08.23 · wallstreetONLINE Redaktion · Intercept Pharmaceuticals